Meningococcal ACWY conjugate vaccine

BIOLOGICAL5 trials

Sponsors

Novartis Vaccines, Novartis

Conditions

Bacterial MeningitisMeningitis, MeningococcalMeningococcal InfectionsMeningococcal Meningitis

Phase 3

A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults

CompletedNCT00450437

Novartis VaccinesMeningococcal Infections, Meningococcal Meningitis

Start: 2007-03-31End: 2008-01-31Updated: 2015-01-28

A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults

CompletedNCT00474487

Novartis VaccinesMeningococcal Infections, Meningococcal Meningitis

Start: 2007-05-31End: 2008-02-29Updated: 2014-04-21

A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants

CompletedNCT00474526

Novartis VaccinesMeningitis, Meningococcal

Start: 2007-03-31End: 2009-11-30Updated: 2014-03-24

Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan

CompletedNCT01410474

NovartisBacterial Meningitis

Start: 2011-08-31End: 2012-01-31Updated: 2014-09-22

Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India

CompletedNCT01547715

NovartisBacterial Meningitis

Start: 2012-03-31End: 2014-04-30Updated: 2018-10-09

Related Papers

Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.

2009-07-0179 citations